Holen Sie sich die Stockscreener-App
100.33
0.42%
0.42
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RVTY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$99.91
Offen:
$98.97
24-Stunden-Volumen:
1.39M
Relative Volume:
0.93
Marktkapitalisierung:
$11.37B
Einnahmen:
$2.77B
Nettoeinkommen (Verlust:
$286.61M
KGV:
42.69
EPS:
2.35
Netto-Cashflow:
$524.11M
1W Leistung:
+4.48%
1M Leistung:
-10.33%
6M Leistung:
+9.41%
1J Leistung:
-12.54%
1-Tages-Spanne:
$98.50
$101.37
1-Wochen-Bereich:
$93.94
$101.37
52-Wochen-Spanne:
$81.36
$120.39
Revvity Inc Stock (RVTY) Company Profile
Firmenname
Revvity Inc
Sektor
Branche
Telefon
781-663-6900
Adresse
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
100.33 | 11.33B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
510.93 | 193.53B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
209.50 | 149.33B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
635.66 | 50.36B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
122.90 | 35.73B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
333.33 | 32.24B | 3.17B | 642.63M | 539.81M | 10.77 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-12-09 | Eingeleitet | Goldman | Neutral |
| 2025-10-16 | Eingeleitet | Guggenheim | Neutral |
| 2025-05-01 | Hochstufung | UBS | Neutral → Buy |
| 2025-01-10 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-07-08 | Eingeleitet | Leerink Partners | Outperform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-01-16 | Herabstufung | UBS | Buy → Neutral |
| 2024-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-05-23 | Fortgesetzt | Goldman | Buy |
Alle ansehen
Revvity Inc Aktie (RVTY) Neueste Nachrichten
Can Revvity Inc. stock hit record highs againExit Point & Risk Controlled Daily Plans - mfd.ru
King Luther Capital Management Corp Has $10.45 Million Stake in Revvity Inc. $RVTY - MarketBeat
Revvity tackles hidden TB threat with early testing strategy - Traders Union
Bretton Fund exits UNP and RVTY - MSN
Revvity Inc. (NYSE:RVTY) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Tesla, AMD, SMCI, Nike, Revvity: Stocks Making The Biggest Moves Today - MSN
Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter - MSN
How To YieldBoost Revvity To 22.5% Using Options - Nasdaq
First National Bank of Omaha Buys New Position in Revvity Inc. $RVTY - MarketBeat
Revvity to Present at Upcoming Investor Conferences - pharmiweb.com
A major biomanufacturer is cutting over 100 jobs in Mass. - MSN
Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Pioneer With 24.51% Upside Potential - DirectorsTalk Interviews
Discipline and Rules-Based Execution in RVTY Response - Stock Traders Daily
What’s the beta of Revvity Inc. stockJuly 2025 Setups & Technical Pattern Alert System - mfd.ru
Can Revvity Inc. stock double in the next yearMarket Trend Summary & Verified Technical Signals - mfd.ru
Revvity Expands Drug Discovery Tools As Investors Weigh Growth And Valuation - Sahm
Here's Why Revvity (RVTY) is a Strong Momentum Stock - Eastern Progress
With Revvity, Inc. (NYSE:RVTY) It Looks Like You'll Get What You Pay For - 富途牛牛
Will Revvity Inc. stock see insider buyingSwing Trade & Capital Efficiency Focused Ideas - mfd.ru
New York Life Investment Management LLC Acquires 11,583 Shares of Revvity Inc. $RVTY - MarketBeat
A | Is Revvity, Inc. showing insider buyingJuly 2025 Fed Impact & High Accuracy Swing Trade Signals - mfd.ru
What insider trading reveals about Revvity Inc. stockQuarterly Portfolio Summary & Safe Capital Growth Trade Ideas - mfd.ru
Revvity Unveils SLAS2026 Platforms As Valuation Gap Attracts Attention - Sahm
Can Revvity Inc. outperform in the next rallyJuly 2025 Gainers & Reliable Entry Point Trade Alerts - mfd.ru
Revvity unveils new high-impact discovery platforms and showcases recent innovations at SLAS2026 - MSN
Revvity boosts momentum at SLAS2026 with full session lineup - Traders Union
Optical Preclinical Imaging Market size to hit $982.8 Million - openPR.com
Revvity Expands Automation Platforms At SLAS2026 As Investors Weigh Long Term Upside - Sahm
Carterra Launches Industry’s First 48-channel HT-SPR Platform for Advanced Label-free Biomolecular Screening and Characterization - GlobeNewswire Inc.
Revvity showcases industry insights at SLAS2026 opening - Traders Union
Winners Losers: Can Revvity Inc outperform in the next rally2025 EndofYear Setup & Short-Term High Return Strategies - baoquankhu1.vn
Diamond Hill Capital Management Inc. Acquires New Holdings in Revvity Inc. $RVTY - MarketBeat
Downgrade Watch: Is Revvity Inc showing insider buyingInsider Buying & AI Forecasted Stock Moves - baoquankhu1.vn
Revvity stock rating reiterated at Overweight by KeyBanc - Investing.com Nigeria
Revvity delivers Q4 beat as earnings and revenue top forecasts - MSN
Assessing Revvity (RVTY) Valuation After New SLAS2026 Lab Automation Launches - Sahm
Momentum Shift: Is Revvity Inc impacted by rising ratesQuarterly Earnings Report & Short-Term High Return Ideas - baoquankhu1.vn
Revvity Inc (RVTY) Shares Gap Down to $100.55 on Feb 5 - GuruFocus
Revvity (RVTY) Deepens AI And Buybacks Strategy: Is Diagnostics Now Its Core Value Engine? - simplywall.st
Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026 - ChartMill
Truist Financial Corp Decreases Stake in Revvity Inc. $RVTY - MarketBeat
Revvity (RVTY) Receives a Buy from UBS - The Globe and Mail
Behavioral Patterns of RVTY and Institutional Flows - Stock Traders Daily
Revvity Inc.: How a Quiet Lab-Tech Powerhouse Is Rewiring the Future of Diagnostics and Drug Discove - AD HOC NEWS
Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (THC), Revvity (RVTY) and Biogen (BIIB) - The Globe and Mail
Revvity advances AI-driven scientific discovery with Signals Xynthetica - MSN
Cowen & Co. Maintains Hold on Revvity (RVTY) Feb 03, 2026 - Meyka
Revvity stock price target raised to $124 from $120 at TD Cowen - Investing.com Canada
Revvity stock rating reiterated at Overweight by KeyBanc By Investing.com - Investing.com South Africa
JPMorgan Chase & Co. Issues Positive Forecast for Revvity (NYSE:RVTY) Stock Price - MarketBeat
JP Morgan Raises Revvity (RVTY) Price Target to $105.00 | RVTY S - GuruFocus
Finanzdaten der Revvity Inc-Aktie (RVTY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Revvity Inc-Aktie (RVTY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Singh Prahlad R. | Please See Remarks |
Feb 05 '26 |
Sale |
100.21 |
25,525 |
2,557,859 |
120,213 |
| Goldberg Joel S | Please See Remarks |
Feb 05 '26 |
Option Exercise |
92.09 |
12,717 |
1,171,109 |
55,964 |
| Goldberg Joel S | Please See Remarks |
Feb 05 '26 |
Sale |
100.21 |
12,717 |
1,274,357 |
43,247 |
0.01%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):